Taxus produces similar outcomes in men & women

Results of a gender-specific study to assess the efficacy of the Taxus paclitaxel-eluting coronary stent in women undergoing coronary revascularisation were released at the European Society of Cardiology Congress by interventional device developer Boston Scientific.

Photo: Taxus produces similar outcomes in men & women

Named Taxus Woman, the study indicates that paclitaxel-eluting stents have similar clinical outcomes in women and men, despite the higher risk profile in female patients.
The researchers analysed pooled results of women enrolled in trials to evaluate the performance of the Taxus stent compared with a bare-metal stent used in control patients with coronary artery disease. The women’s results were compared with the corresponding endpoints in men.
According to the Massachusetts-based firm, there were no other significant differences in baseline demographics, and lesion or procedural characteristics between the Taxus and bare-metal stent groups in both genders.

30.10.2007

Related articles

Photo

Article • Cardiology congress

ESC 2018: At the heart of research

When delegates from around 150 countries converge on Munich for ESC Congress 2018 they will no doubt reflect on what they themselves eat. Yes, nutrition is up for debate, questioning, for example,…

Photo

News • Cardiovascular MR

Standard medical tests miss nearly two-thirds of heart attack diagnoses

Standard medical tests miss nearly two-thirds of heart attack diagnoses, reveals research presented at CMR 2018. “Unrecognised MI has a poor short-term prognosis but until now the long-term outlook…

Photo

Article •

Computerised model of the heart to develop new therapies

During a workshop organized by the European Science Foundation (ESF), researchers discussed further steps in developing computerised “in-silico” models of the heart that simulate the real heart…

Related products

Subscribe to Newsletter